Table 1.

Hemodynamic parameters in control (Group I), CEL per se (Group II), BPS (Group III), CEL + BPS (Group IV).

Group	SBP(mmHg)	DBP(mmHg)	MAP(mmHg)	HR (BPM)
I	109.08 ± 2.35	83.22 ± 4.38	91.83 ± 3.53	322.06 ± 20.13
II	125.78 ± 4.00*	88.91 ± 2.61	101.19 ± 2.42	358.88 ± 16.58
III	102.45 ± 4.99	79.59 ± 2.56	88.73 ± 5.55	310.39 ± 9.76
IV	106.15 ± 2.56**	74.73 ± 2.80	86.37 ± 3.91	308.23 ± 18.81

Values are expressed as mean ± SEM (n = 8) and analyzed by one-way ANOVA followed by Tukey-Kramer multiple comparison test.

^* p < 0.01 II v/s I and

^** p < 0.01 IV v/s II. CEL: Celecoxib; BPS: Beraprost Sodium; SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; HR: heart rate.